生命科学资讯

Illumina Q4 Earnings Call Highlights - Yahoo Finance

Agomab, SpyGlass bank a combined $350M in biotech IPOs

FDA chief Makary takes aim at Hims' compounded Wegovy pill plans

Illumina: Q4 Earnings Snapshot - kens5.com

Illumina shares tumble as flat revenue disappoints investors By Investing.com - Investing.com

Illumina Inc. Q4 Profit Advances - Nasdaq

Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game

Novo's threat to sue Hims over Wegovy pill faces legal hurdle

Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025 - TradingView

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 - PR Newswire

White House plans to launch TrumpRx Thursday

Astellas tops expectations as Vyloy sales surge outshines trial setback

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA

A hack-proof internet? Quantum encryption could be the key

Veradermics CEO has a great hair day with 122% pop in IPO

Novo, Lilly sputter as Hims launches knockoff GLP-1 pill

#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial

Bayer details anticipated stroke prevention data for new blood-thinner

Appointments and advancements for Feb. 5, 2026

Financings for Feb. 5, 2026